4//SEC Filing
DeSantis Damon 4
Accession 0001345281-22-000002
CIK 0001016504other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:33 PM ET
Size
5.6 KB
Accession
0001345281-22-000002
Insider Transaction Report
Form 4
DeSantis Damon
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-20+50,000→ 50,000 totalExp: 2032-06-20→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date.
- [F2]The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023.
Documents
Issuer
INTEGRATED BIOPHARMA INC
CIK 0001016504
Entity typeother
Related Parties
1- filerCIK 0001889279
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:33 PM ET
- Size
- 5.6 KB